missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ERGIC1 (aa 127-189) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53874 (PA5-53874. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The function of ERGIC1 remains largely unknown. ERGIC1 was highly expressed in most primary prostate tumors. It is an intriguing potential drug target especially for the ERG oncogene expressing tumors.
Specifications
Specifications
| Accession Number | Q969X5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 57222 |
| Name | Human ERGIC1 (aa 127-189) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1200007D18Rik; endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1; endoplasmic reticulum-golgi intermediate compartment 1; endoplasmic reticulum-golgi intermediate compartment 32 kDa protein; endoplasmic reticulum-Golgi intermediate compartment protein 1; ERGIC1; ERGIC32; ERGIC-32; ER-Golgi intermediate compartment 32 kDa protein; HT034; KIAA1181; maa-136; mKIAA1181 protein-like; NET24 |
| Common Name | ERGIC1 |
| Show More |